bioAffinity Technologies (BIAF) Depreciation & Amortization (CF) (2021 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Depreciation & Amortization (CF) of $114518.0 for Q1 2026, down 25.92% year-over-year from $154588.0 in Q1 2025, and down 7.39% quarter-over-quarter from $123659.0 in Q4 2025.
bioAffinity Technologies (BIAF) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Depreciation & Amortization (CF) for 6 consecutive years, with $114518.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 25.92% year-over-year to $114518.0; the TTM figure through Mar 2026 stood at $464766.0 (down 23.88% YoY), while the FY2025 annual figure was $504836.0, down 16.64% from the prior year.
- Depreciation & Amortization (CF) declined to $114518.0 in Q1 2026 per BIAF's latest filing, from $123659.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $154588.0 in Q1 2025 and bottomed at $773.0 in Q3 2022.
- Historically, Depreciation & Amortization (CF) has averaged $87339.1 across 5 years, with a median of $113360.0 in 2025.
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) soared 7347.48% — and 2026, when it decreased 25.92%.
- bioAffinity Technologies' Depreciation & Amortization (CF) stood at $7330.0 in 2022, then soared by 1929.84% to $148787.0 in 2023, then rose by 3.26% to $153632.0 in 2024, then decreased by 19.51% to $123659.0 in 2025, then declined by 7.39% to $114518.0 in 2026.
- Business Quant data shows BIAF's Depreciation & Amortization (CF) at $114518.0 in Q1 2026, $123659.0 in Q4 2025, and $113360.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 15.48 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 67.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 292.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 41.05 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 179.00 Mn |
| 10 | bioAffinity Technologies | 1.78 Mn | -649,139.45 | - | 61,556.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61,556.00 |
| Jun 30, 2026 | 61,556.00 |
| Mar 31, 2026 | 114,518.00 |
| Mar 31, 2026 | 114,518.00 |
| Dec 31, 2025 | 123,659.00 |
| Dec 31, 2025 | 123,659.00 |
| Sep 30, 2025 | 113,360.00 |
| Sep 30, 2025 | 113,360.00 |
| Jun 30, 2025 | 113,229.00 |
| Jun 30, 2025 | 113,229.00 |
| Mar 31, 2025 | 154,588.00 |
| Mar 31, 2025 | 154,588.00 |
| Dec 31, 2024 | 153,632.00 |
| Dec 31, 2024 | 153,632.00 |
| Sep 30, 2024 | 151,298.00 |
| Sep 30, 2024 | 151,298.00 |
| Jun 30, 2024 | 151,070.00 |
| Jun 30, 2024 | 151,070.00 |
| Mar 31, 2024 | 149,637.00 |
| Mar 31, 2024 | 149,637.00 |